Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Net Margin (2022 - 2023)

Historic Net Margin for Lexeo Therapeutics (LXEO) over the last 2 years, with Q4 2023 value amounting to 28374.0%.

  • Lexeo Therapeutics' Net Margin changed N/A to 28374.0% in Q4 2023 from the same period last year, while for Dec 2023 it was 32386.83%, marking a year-over-year change of. This contributed to the annual value of 71775.91% for FY2024, which is 393886000.0% up from last year.
  • Latest data reveals that Lexeo Therapeutics reported Net Margin of 28374.0% as of Q4 2023.
  • Lexeo Therapeutics' 5-year Net Margin high stood at 38669.23% for Q3 2023, and its period low was 3211.86% during Q3 2022.